Further research is exploring the long-term effects and optimal treatment strategies, but the potential of GLP-1 medications to improve reproductive health and fertility outcomes in women with PCOS is encouraging
Combining tirzepatide with HCG theoretically targets both appetite suppression (tirzepatide) and metabolic energy mobilization (HCG), reducing the likelihood of adaptive resistance
Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Companys ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR
Research shows that weight regain begins immediately once GLP-1 agonists are stopped, with most patients returning to baseline weight within 3 to 6 months
Some clinical studies show that oral glutathione (at doses such as 250500 mg per day) may reduce the melanin index in sun-exposed areas, leading to measurable skin brightening